Verastem, Inc. Restructuring Charges
Verastem, Inc. (VSTM) reported Restructuring Charges of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2022-03-28
- Verastem, Inc. restructuring charges for the quarter ending 2021-12-31 was $0.00.
- Verastem, Inc. restructuring charges for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- Verastem, Inc. restructuring charges for the quarter ending 2021-06-30 was $0.00.
- Verastem, Inc. restructuring charges for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- Verastem, Inc. restructuring charges for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Verastem, Inc. restructuring charges for fiscal 2020 was $4.78M.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $0.00 derived: sum of 2 quarters · filed 2022-03-28 | $0.00 derived: sum of 3 quarters · filed 2022-03-28 | $0.00 10-K · filed 2022-03-28 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $0.00 derived: sum of 2 quarters · filed 2021-11-04 | $0.00 10-Q · filed 2021-11-04 | $0.00 derived: sum of 4 quarters · filed 2021-11-04 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-02 | $0.00 10-Q · filed 2021-08-02 | $0.00 derived: sum of 3 quarters · filed 2021-08-02 | $2.99M derived: sum of 4 quarters · filed 2021-08-02 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-11 | $0.00 derived: sum of 2 quarters · filed 2021-05-11 | $2.99M derived: sum of 3 quarters · filed 2021-05-11 | $2.99M derived: sum of 4 quarters · filed 2021-05-11 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $2.99M derived: sum of 2 quarters · filed 2021-03-18 | $2.99M derived: sum of 3 quarters · filed 2021-03-18 | $4.78M 10-K · filed 2021-03-18 |
| 2020-09-30 | $2.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $2.99M derived: sum of 2 quarters · filed 2020-11-09 | $4.78M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $1.79M 10-Q · filed 2020-08-10 | ||
| 2020-03-31 | $1.79M 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |